Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Orifarm, officially known as Orifarm Group, is a prominent player in the medical, precision, and optical instruments sector, headquartered in Denmark (DK). Established in 1994, the company has made significant strides in the industry, focusing on the development and distribution of high-quality pharmaceuticals and medical devices.
With a strong presence in Europe and beyond, Orifarm is renowned for its commitment to innovation and quality, offering a diverse range of products that include generic medicines and specialty pharmaceuticals. Their unique approach to product development and stringent quality control measures have positioned them as a trusted partner in healthcare.
Orifarm's dedication to sustainability and patient-centric solutions has earned them a notable reputation, making them a key player in the competitive landscape of medical instruments and pharmaceuticals.
+27 vs industry average
Orifarm’s score of 59 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has below-average carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
Orifarm, headquartered in Denmark and operating in the Medical, precision and optical instruments, watches and clocks industry, reported Scope 1 emissions of 3,178,000 kg CO2e and Scope 2 market-based emissions of 7,300,000 kg CO2e for 2024. In 2023, their Scope 1 emissions were 4,420,000 kg CO2e, with Scope 2 market-based emissions at 7,529,000 kg CO2e. This data is cascaded from Orifarm Group A/S.
Orifarm has set several climate commitments. They aim to reduce their Scope 1 and Scope 2 CO2 emissions by 30% by 2025 from a 2020 baseline. Additionally, Orifarm Group A/S, the source of their cascaded data, has committed to Science Based Targets initiative (SBTi) near-term targets to reduce absolute Scope 1 and Scope 2 greenhouse gas emissions by 54.6% by 2033 from a 2023 base year. They also aim to reduce absolute Scope 3 greenhouse gas emissions by 32.5% within the same timeframe. Orifarm Group A/S also has a long-term net-zero commitment, with an aim for exponential reduction in absolute emissions towards 2050.
2033
54.6% reduction in Scope 1
2033
54.6% reduction in Scope 1
2033
54.6% reduction in Scope 2
See all 5 climate goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Orifarm’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more